CenterMed Lublin Spzoo

Lublin 20-044

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Coronary Heart Disease (CHD), Diabetes Mellitus, Type 1, High Cardiovascular Risk, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro — Withdrawn before enrolling
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed